Blog Category

Category: Angel Group News

Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2023 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report
September 24 MEMBER NEWS: Great Lakes Angels Invests in Angels, Entrepreneurs with Angel Resource Institute’s Educational Workshop

Great Lakes Angels is hosting the Angel Investing Overview, an Angel Resource Institute education program on angel investing, at UHY Advisors (27725 Stansbury Blvd., Suite 100, Farmington Hills, MI 48334) on December 3rd. Angel Investing Overview (AIO) is the leading seminar for educating angel investors, entrepreneurs, and startup support professionals about how to execute the angel investment […]

Read More
September 08 From Startup to Public Company: ProNAi Therapeutics is a Michigan Success Story

The road from company formation to successful exit is a tenuous one, even when the startup is well-capitalized and quickly finds a profitable niche in the marketplace. For a biotech company developing drug therapies, their survival to test the drug safety and efficacy for many years, sometimes a decade or more, is highly dependent on […]

Read More
June 30 Great Lakes Angels welcomes new president Pietro Sarcina

Angel investment activity is increasingly important in Michigan’s entrepreneurial economy, so we’re always pleased when one of our nine Michigan angel groups report exciting news!  The Great Lakes Angels (GLA) are announcing the appointment of Pietro Sarcina as President, effective July 1, 2015; David Weaver will remain as Chairman and Founder. Weaver reflects, “We are very fortunate to have someone […]

Read More
April 21 Angel-backed RetroSense Therapeutics Recognized as National Innovator

Angel investors might invest in one of every 100 opportunities that come before them—long odds for a startup, for sure. Ann Arbor-based RetroSense Therapeutics, a privately-held biopharmaceutical company, had already beat those odds, having raised $7 million in a 2014 angel-led Series A financing round that included Midland’s Blue Water Angels Investment Network. But the […]

Read More